Last reviewed · How we verify
NCT06983756
" Evaluation of Erythropoietin Therapy in Patients With End-Stage Kidney Disease on Regular Hemodialysis: Hemoglobin Outcomes, and Metabolic Syndrome as a Risk Factor for Erythropoietin Resistance "
trial testing Erythropoietin in Erythropoietin Resistant Anemia (EPO Resistant Anemia) in 66 participants. Not yet recruiting.
1 December 2025
Quick facts
| Lead sponsor | Fayoum University |
|---|---|
| Status | Not yet recruiting |
| Study type | OBSERVATIONAL |
| Enrollment | 66 |
| Start date | 1 June 2025 |
| Primary completion | 1 December 2025 |
| Estimated completion | 1 January 2026 |
Drugs / interventions tested
- Erythropoietin — full drug profile →
Conditions studied
- Erythropoietin Resistant Anemia (EPO Resistant Anemia) — all drugs for Erythropoietin Resistant Anemia (EPO Resistant Anemia) →
Sponsor
Fayoum University
Who can join
18 and older, any sex, with Erythropoietin Resistant Anemia (EPO Resistant Anemia). Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The primary aim of this study is to investigate the association between metabolic syndrome and erythropoietin resistance in patients with End-Stage Kidney Disease (ESKD).
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT06983756
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Erythropoietin
Trials testing the same drug.
- NCT06590155 — Erythropoietin in HIE Neonate · EARLY_PHASE1 · not yet recruiting
- NCT06542393 — PBM as Strategy to CABG Anemic Patients Bypass Graft (CABG) · Phase 2 · recruiting
- NCT05395195 — Erythropoietin for Neonatal Encephalopathy in LMIC (EMBRACE Trial) · Phase 3 · recruiting
- NCT05300477 — Pharmacological Countermeasures for High Altitude · Phase 4 · active not recruiting
- NCT05325073 — Erythropoietin Therapy to Induce Regulatory T Cells in Liver Transplant Recipients · Phase 4 · active not recruiting
Other Fayoum University trials
Trials by the same sponsor.
- NCT07536620 — Metformin and Alveolar Cleft · Phase 2 · not yet recruiting
- NCT07444970 — Comparative Evaluation of Xenograft Alone and Sticky Bone in Sinus Lift With Concurrent Implant Placement · NA · not yet recruiting
- NCT07394179 — Transforming Channel Osteotomy Into Tunnel Osteotomy in Zygomatic Implant Preparation · NA · not yet recruiting
- NCT07277348 — Analysis of The Outcomes of Therapeutic Photorefractive Keratectomy Combined With Prophylactic Accelerated Cross-Linking · NA · not yet recruiting
- NCT07330726 — Lidocaine Patch and Lower Third Molar · Phase 3 · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06983756 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Fayoum University
- Last refreshed: 21 May 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06983756.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing